Atherosclerosis and systemic lupus erythematosus: the role of altered lipids and of autoantibodies
Authors:
- 1 May 2008
- journal article
- research article
- Published by SAGE Publications in Lupus
- Vol. 17 (5) , 368-370
Abstract
The accelerated atherosclerosis that occurs in some patients with systemic lupus erythematosus (SLE) has a complex pathogenesis, including alterations in lipids, inflammation and the immune system. In this article, we review the evidence that peroxidase-related alteration of normal, protective high-density lipoprotein (HDL) converts them to pro-inflammatory HDL (piHDL), characterized by lower content of the cholesterol transport lipoprotein ApoA1 and impaired function of the antioxidant enzyme paroxonase, which prevents oxidation of low-density lipoprotein (LDL). Forty-five per cent of women with SLE have piHDL compared with 20% of patients with rheumatoid arthritis and 4% of healthy controls. The presence of piHDL increases risk for coronary artery events and carotid artery plaque. Another result of lipid oxidation in patients with SLE is generation of highly oxidized LDL and phospholipids (PL), probably stimulating antibodies to OxPL phospholipids. These antibodies along with promoting thrombosis also interfere with deposits of Annexin V onto endothelial cells, which probably promote increased instability of atherosclerotic plaque. Thus, piHDL and anti-OxPL promote plaque formation, plaque instability and thrombosis, accounting for some of the large increase in atherosclerosis and coronary artery events in SLE.Keywords
This publication has 8 references indexed in Scilit:
- Atherosclerosis and systemic lupus erythematosus — mechanistic basis of the associationCurrent Opinion in Immunology, 2007
- Annexin A5 as a Novel Player in Prevention of Atherothrombosis in SLE and in the General PopulationAnnals of the New York Academy of Sciences, 2007
- ApoE−/−Fas−/− C57BL/6 mice: a novel murine model simultaneously exhibits lupus nephritis, atherosclerosis, and osteopeniaJournal of Lipid Research, 2007
- Antibodies of IgM subclass to phosphorylcholine and oxidized LDL are protective factors for atherosclerosis in patients with hypertensionAtherosclerosis, 2006
- Proinflammatory high‐density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritisArthritis & Rheumatism, 2006
- Lipid peroxidation is enhanced in patients with systemic lupus erythematosus and is associated with arterial and renal disease manifestationsArthritis & Rheumatism, 2005
- Decreased Binding of Annexin V to Endothelial CellsArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Prevalence and Correlates of Accelerated Atherosclerosis in Systemic Lupus ErythematosusNew England Journal of Medicine, 2003